American College of Neuropsychopharmacology Inc. Neuropsychopharmacology
subscribe to npp
SEARCH
Advanced search
My Account E-alerts Subscribe Register Help
Journal home
Current Issue
Advance Online Publication
Archive
Online sample issue FREE!
Author index
Keyword index
For authors
Editorial Board
Instructions for authors
Aims and scope
Indexed in
Author queries
Online Submission
Customer Services
Subscription information
Journal prices
Order sample issue
Purchase articles,
reprints & permissions
Advertising
Contact NPG
nature.com
Original Article
Neuropsychopharmacology (1999) 20 188-197.10.1038/sj.npp.1395241

Serotonergic and Noradrenergic Markers of Post-Traumatic Stress Disorder with and without Major Depression

Michael Maes1,2,3 MD, Ph.D, Ai-hua Lin1 MD, MSci, Robert Verkerk4 Ing, Laure Delmeire1 MD, An Van Gastel MD, Marc Van der Planken5 MD, Ph.D and Simon Scharpé4 Ph.D
1Clinical Research Center for Mental Health [CRC-MH], Antwerp, Belgium
2Department of Psychiatry, Vanderbilt University, Nashville, Tennessee, USA
3IRCSS, Fatebenefratelli, Brescia, Italy
4Department of Medical Biochemistry, University of Antwerp, Wilrijk USA
5Department of Hematology, University Hospital of Antwerp, Antwerp, Belgium

Correspondence: Dr Michael Maes, Director Clinical Research Center for Mental Health (CRC-MH), University Department of Psychiatry, AZ Stuivenberg,Lange Beeldekensstraat 267, 2060 Antwerpen, Belgium

ABSTRACT

Some studies have suggested that disorders in the peripheral and central metabolism of serotonin (5-HT) and noradrenaline (NE) may play roles in the pathophysiology of post-traumatic stress disorder (PTSD). This study examines (1) the availability of plasma total tryptophan, the precursor of 5-HT, and tyrosine, the precursor of NE; and (2) the platelet 5-HT transporter and alpha2-adrenoceptor (alpha2-AR) binding sites in patients with PTSD and healthy volunteers. High-performance liquid chromatography (HPLC) was employed to measure plasma tryptophan and tyrosine as well as amino acids known to compete with the same cerebral transport system; that is, valine, leucine, phenylalanine, and isoleucine. The maximum number of binding sites (Bmax) and their affinity (Kd) for binding to [3H]-paroxetine and [3H]-rauwolscine, a selective alpha2-AR antagonist, were determined. [3H]-paroxetine and [3H]-rauwolscine binding Kd values were significantly higher in patients with PTSD than in healthy volunteers. [3H]-rauwolscine binding Kd values were significantly higher in patients with PTSD and concurrent major depression (MD) than in PTSD patients without MD and healthy volunteers. Plasma tyrosine concentrations and the ratio of tyrosine/valine + leucine + isoleucine + phenylalanine + tryptophan were significantly higher in PTSD patients with MD than in those without MD and healthy volunteers. The results show that PTSD is accompanied by lower affinity of paroxetine binding sites and that PTSD with concurrent MD is accompanied by lower affinity of alpha2-ARs and increased plasma tyrosine availability to the brain. The results suggest that (1) serotonergic mechanisms, such as defects in the 5-HT transporter system, may play a role in the pathophysiology of PTSD; and (2) that catecholaminergic mechanisms, such as increased precursor availability and lowered affinity of alpha2-ARs, may play a role in the pathophysiology of PTSD with concurrent MD.

Keywords: Post-traumatic stress disorder; Depression; Serotonin; Norepinephrine; Tryptophan; Tyrosine
  top go to top
Article Links
Send to a friend Send to a friend
Download PDF Download PDF
Full Text Full Text
 Next Article Next Article
 Previous Article Previous Article
 Table of Contents Table of Contents
Privacy Policy Copyright © 1999 by the American College of Neuropsychopharmacology